Companies /Healthcare

Novo Nordisk A/S

NYSE: NVO Drug Manufacturers - General
$42.53
▼ $0.92 (−2.12%) today
Markets closed · 10:54pm ET

NVO Coverage

Page 11
4:01am ET
Health and Healthcare

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…

Douglas A. McIntyre